Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06578650 · ClinicalTrials.gov registry record
A Prospective, Single-arm, Clinical Trial of Electrospun Fiber Matrix (Restrata) in the Treatment of Surgical Defects Secondary to Resection of Malignant Cutaneous Neoplasms
A clinical trial of Surgical Wound, sponsored by Acera Surgical.
- Recruiting
- Registry status
- 34
- Enrollment target
- 1
- Study location
NCT06578650: Recruiting study of Surgical Wound, sponsored by Acera Surgical.
NCT06578650 is a study of Surgical Wound that is actively recruiting participants, run by Acera Surgical. The registered enrollment target is 34 participants, below the 93-participant average among 17 other Surgical Wound trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06578650, a study of Surgical Wound, is actively recruiting participants, sponsored by Acera Surgical.
- RECRUITING
- Registry status
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational prospective study is to evaluate wound healing outcomes in resection wounds resulting from surgical removal of cutaneous malignancies treated with a synthetic electrospun fiber matrix. This study intends to quantify the time from initial resection and product application to time of complete granulation of the wound bed in weeks.
Primary Outcome
Time from initial resection and product placement to the time of at least 75% wound bed granulation using a modified Bates-Jenson Scale. The Bates-Jenson Scale for Granulation Tissue ranges from: 1=Skin intact or partial thickness wound, to: 5=No granulation tissue present. Wounds are considered "granulated" upon receiving a rating of 2 (Bright, beefy red;75% to 100% of wound filled \&/or tissue overgrowth) or less upon investigator assessment. Lower scores are indicative of better outcomes.
Conditions Studied
Interventions
- DEVICE Synthetic Electrospun Fiber Matrix
Study Locations (1)
Nevada
- University Nevada - Las Vegas - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2024-10-31 |
| Est. Completion | 2027-05 |
What NCT06578650 shows while recruiting
NCT06578650 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 93-participant average among 17 other Surgical Wound trials with a reported enrollment target (63% lower).
The record links to 1 condition, with Surgical Wound appearing as the primary indexed condition, and to 1 intervention - of which Synthetic Electrospun Fiber Matrix is the first listed.
NCT06578650 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT06578650 about?
NCT06578650 is a clinical study titled "A Prospective, Single-arm, Clinical Trial of Electrospun Fiber Matrix (Restrata) in the Treatment of Surgical Defects Secondary to Resection of Malignant Cutaneous Neoplasms". The goal of this observational prospective study is to evaluate wound healing outcomes in resection wounds resulting from surgical removal of cutaneous malignancies treated with a synthetic electrospun fiber matrix. This study intends to quantify the time from initial resection and product applicati...
What is the current status of trial NCT06578650?
This trial is currently recruiting. The enrollment target is 34 participants. The study started on 2024-10-31. Estimated completion is 2027-05.
What conditions does trial NCT06578650 study?
This clinical trial studies the following conditions: Surgical Wound.
What interventions are being tested in trial NCT06578650?
The interventions under investigation include: Synthetic Electrospun Fiber Matrix (DEVICE).
Who is sponsoring clinical trial NCT06578650?
This trial is sponsored by Acera Surgical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06578650 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgical Wound
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06578650's enrollment target sits among peer trials
34 14th of 17 higher than 4 of 17 other Surgical Wound trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Surgical Wound trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Zinc Oxide Versus Petrolatum Following Skin Surgery
RECRUITING · Early Phase 1
-
Evaluating rhPDGF-BB-Enhanced Wound Matrix for Head and Neck Reconstruction
RECRUITING · Phase 2
-
Early Versus Delayed Bathing of Orthopaedic Surgical Wounds
RECRUITING · NA
-
fMRI and IVCM Cornea Microscopy of CXL in Keratoconus
RECRUITING
-
Regenn® Therapy System Safety Study
RECRUITING · Phase 1
-
Multicenter Single-arm Trial to Investigate Clinical Outcomes When Cohealyx™ is Used for Full Thickness Wounds
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI